Chlamydia pneumoniae-atherosclerosis link: a sound concept in search for clinical relevance.
Neumann
Franz-Josef
FJ
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000907:Antibodies, Bacterial / Q000097:blood; D001161:Arteriosclerosis / Q000382:microbiology* / Q000401:mortality / Q000517:prevention & control; D017963:Azithromycin / Q000627:therapeutic use; D023521:Chlamydophila Infections / Q000150:complications* / Q000188:drug therapy; D016993:Chlamydophila pneumoniae; D005500:Follow-Up Studies; D006801:Humans; D009017:Morbidity; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D012008:Recurrence; D015575:Roxithromycin / Q000627:therapeutic use; D018401:Sample Size; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D015575:Roxithromycin; D017963:Azithromycin